Fluidigm's Q2 Revenues Rise 22 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Tuesday that its second-quarter revenues increased 22 percent year over year driven by 79 percent growth for its consumables.

The South San Francisco, Calif.-based firm brought in total revenues of $12.9 million for the three months ended June 30, compared to $10.6 million for the second quarter of 2011. The firm surpassed analysts' consensus estimate of $12.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: parent-of-origin effects, framework to uncover clinically important mutations from whole genome sequence data, and more.

A survey of Cincinnati schoolchildren finds teenagers want to know their genetic predisposition to disease, LiveScience reports.

More and more universities are helping their researchers patent their inventions, the Los Angeles Times reports.

Cancer Research UK unveils seven 'grand challenges' that it will fund researchers to tackle.